この記事の翻訳を準備しています。それまでの間、英語の原文を表示します。
ビジネス · 2021/10/61 分で読めます
Issuance of Priority Review Voucher; Rare Pediatric Disease Product; Withdrawal
ローカル自動翻訳 · 情報源の原言語
概要
The Food and Drug Administration (FDA) is withdrawing the notice that published in the Federal Register of September 30, 2021, that announced the issuance of a priority review voucher to the sponsor of a rare pediatric disease product application. The Federal Register notice was published in error and is being withdrawn.
情報源の原言語: Federal Register — Food and Drug Administration原文の発表を開く →